BARRY M BERNSTEIN,RAJEE M MENON,AMIT KHATRI,SVEN MENSING,SANDEEP DUTTA,DANIEL E COHEN,THOMAS J PODSADECKI,SCOTT C BRUN,WALID M AWNI,EMILY O DUMAS,CHERI E KLEIN
申请号：
HK15100265.1
公开号：
HK1199816A
申请日:
2015.01.09
申请国别(地区):
HK
年份:
2015
代理人:
摘要：
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.
